Collegium Pharmaceutical Inc buy tamam
Start price
21.06.18
/
50%
€24.70
Target price
03.06.19
€36.08
Performance (%)
-57.85%
End price
03.06.19
€10.41
Summary
This prediction ended on 03.06.19 with a price of €10.41. The BUY prediction by tamam for Collegium Pharmaceutical Inc performed very badly with a performance of -57.85%. tamam has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Collegium Pharmaceutical Inc | 0.000% | 0.000% | 43.137% | 46.734% |
iShares Core DAX® | 0.410% | -2.543% | 14.415% | 14.709% |
iShares Nasdaq 100 | -2.154% | 4.721% | 33.222% | 52.436% |
iShares Nikkei 225® | -0.066% | -0.307% | 8.496% | 3.743% |
iShares S&P 500 | -0.527% | 3.848% | 28.621% | 47.348% |
Comments by tamam for this prediction
In the thread Collegium Pharmaceutical Inc diskutieren
Collegium in a huge potential market and solid operational momentum
Collegium continues to see a nice ramp-up in sales of Xtampza.
First-quarter revenues should be very strong as well, as regulatory action following the opioid crisis could make Xtampza a big winner.
(Vom Mitglied beendet)